Healthcare provider profile · identity verified

Jyothi Kundur, MD

Family Practice · SAN ANTONIO, TX · NPI 1164683066

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	445	150
Amlodipine Besylate	Amlodipine Besylate	364	117
Losartan Potassium	Losartan Potassium	354	111
Levothyroxine Sodium	Levothyroxine Sodium	340	104
Lisinopril	Lisinopril	334	101
Rosuvastatin Calcium	Rosuvastatin Calcium	253	83
Metformin Hcl	Metformin Hcl	236	75
Metoprolol Succinate	Metoprolol Succinate	201	62
Gabapentin	Gabapentin	186	70
Hydrochlorothiazide	Hydrochlorothiazide	184	62
Simvastatin	Simvastatin	171	52
Montelukast Sodium	Montelukast Sodium	155	53
Albuterol Sulfate Hfa	Albuterol Sulfate	151	61
Fluticasone Propionate	Fluticasone Propionate	146	81
Pravastatin Sodium	Pravastatin Sodium	142	45
Pantoprazole Sodium	Pantoprazole Sodium	141	68
Glipizide	Glipizide	137	42
Omeprazole	Omeprazole	134	53
Alendronate Sodium	Alendronate Sodium	133	47
Cephalexin	Cephalexin	115	111
Trazodone Hcl	Trazodone Hcl	109	40
Azithromycin	Azithromycin	86	80
Jardiance	Empagliflozin	86	30
Furosemide	Furosemide	85	31
Meloxicam	Meloxicam	84	47
Tamsulosin Hcl	Tamsulosin Hcl	84	31
Potassium Chloride	Potassium Chloride	79	28
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	79	77
Metoprolol Tartrate	Metoprolol Tartrate	76	29
Prednisone	Prednisone	76	72
Escitalopram Oxalate	Escitalopram Oxalate	74	26
Sertraline Hcl	Sertraline Hcl	74	25
Clopidogrel	Clopidogrel Bisulfate	73	19
Ozempic	Semaglutide	66	16
Carvedilol	Carvedilol	61	21
Mirtazapine	Mirtazapine	61	23
Tizanidine Hcl	Tizanidine Hcl	61	39
Baclofen	Baclofen	56	30
Eliquis	Apixaban	56	17
Metformin Hcl Er	Metformin Hcl	51	14
Nifedipine Er	Nifedipine	50	19
Januvia	Sitagliptin Phosphate	48	15
Spironolactone	Spironolactone	47	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	45
Paxlovid	Nirmatrelvir/Ritonavir	45	45
Tramadol Hcl	Tramadol Hcl	45	21
Vitamin D2	Ergocalciferol (Vitamin D2)	45	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	14
Allopurinol	Allopurinol	43	13
Famotidine	Famotidine	43	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	14
Donepezil Hcl	Donepezil Hcl	42	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	12
Fluoxetine Hcl	Fluoxetine Hcl	40	suppressed
Ibuprofen	Ibuprofen	38	18
Atenolol	Atenolol	37	suppressed
Duloxetine Hcl	Duloxetine Hcl	34	12
Finasteride	Finasteride	34	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	22
Benazepril Hcl	Benazepril Hcl	31	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	31	suppressed
Myrbetriq	Mirabegron	30	12
Doxycycline Hyclate	Doxycycline Hyclate	29	28
Fluconazole	Fluconazole	29	23
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Ezetimibe	Ezetimibe	28	11
Lovastatin	Lovastatin	28	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	22
Lantus	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	21	14
Folic Acid	Folic Acid	21	suppressed
Glipizide Er	Glipizide	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	19
Spiriva Handihaler	Tiotropium Bromide	21	suppressed
Glimepiride	Glimepiride	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Alprazolam	Alprazolam	19	11
Celecoxib	Celecoxib	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Clonazepam	Clonazepam	18	11
Enalapril Maleate	Enalapril Maleate	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Nystatin	Nystatin	16	15
Propranolol Hcl	Propranolol Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	12
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Metronidazole	Metronidazole	13	13
Mounjaro	Tirzepatide	13	suppressed
Nitroglycerin	Nitroglycerin	13	13
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Estradiol	Estradiol	12	suppressed
Linzess	Linaclotide	12	suppressed
Praluent Pen	Alirocumab	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	12
Warfarin Sodium	Warfarin Sodium	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Ofloxacin	Ofloxacin	11	11
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error